Drug Profile
Research programme: cancer therapeutic lentivirus - American Gene Technologies
Alternative Names: AG 1103; AG1103- liver cancer therapeutic lentivirusLatest Information Update: 22 Sep 2023
Price :
$50
*
At a glance
- Originator American Gene Technologies International
- Class Antineoplastics; Gene therapies
- Mechanism of Action Angiogenesis inhibitors; Cell division inhibitors; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 22 Sep 2023 Preclinical development is ongoing in USA (American Gene Technologies pipeline September 2023)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
- 13 Mar 2018 American Gene Technologies International has patent protection for its lentiviral vector technology in USA